ReviewJournal of neural transmission (Vienna, Austria : 1996)2025
Cognitive disorders and parkinson's disease: a literature review.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Parkinson's disease patients with subjective cognitive decline.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's Disease (PD) is a movement disorder characterized by tremors, rigidity, and bradykinesia, accompanied by several non-motor symptoms, with cognitive impairment as one of the most debilitating. This narrative review of literature aims to provide a general overview on the defining features, pathologic changes, and management principles of cognitive changes in PD. A literature review was conducted by searching the terms "Cognition" OR "Cognitive Decline", AND "Parkinson's Disease" in PubMed, Scopus, and Google Scholar. Mild cognitive impairment (PD-MCI) and dementia (PDD) have been well-defined with consensus criteria. Recent researches have focused on pathophysiologic changes, identifying patterns of atrophy, as well as corresponding neurochemical insults. These have been primarily targeted in the existing pharmacologic literature, with evidence for non-pharmacologic therapies still lacking. Cognitive changes in PD range from a spectrum of mild cognitive impairment (PD-MCI) to dementia (PDD). Evidence exists for clinical and pathologic mechanisms which guide current and future therapeutic principles. Current trends of research are focused on the potential of discovering preventive therapies strengthens the need for more high-level evidence in the future.
Indexed as
Identifiers
40679622What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.